Karolinska Development

Karolinska Development company information, Employees & Contact Information

Karolinska Development AB is an investment company focused on identifying medical innovation and investing in the creation and growth of companies developing these assets into differentiated products that will make a difference to patients’ lives and provide an attractive return on investment. Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region. The Company aims to build companies around scientists who are leaders in their fields, supported by experienced management teams and advisers, and co-funded by specialist international investors, to provide the greatest chance of success. Karolinska Development has established a portfolio of 10 companies targeting opportunities in innovative treatment for life-threatening or serious debilitating diseases. The Company is led by a team including investment professionals with strong venture capital backgrounds, experienced company builders and entrepreneurs, with access to a strong global network. For more information, please visit www.karolinskadevelopment.com

Company Details

Employees
26
Founded
-
Address
Nanna Svartz Väg 6a, Solna,stockholm County 17165,sweden
Phone
+46 72 858 32 09
Email
in****@****ent.com
Industry
Venture Capital And Private Equity Principals
NAICS
Miscellaneous Intermediation
HQ
Solna, Stockholm County
Looking for a particular Karolinska Development employee's phone or email?

Karolinska Development Questions

News

Karolinska Development invests SEK 7.5 million to support BOOST Pharma’s continued development of BT-101 towards Phase 3 - The Manila Times

Karolinska Development invests SEK 7.5 million to support BOOST Pharma’s continued development of BT-101 towards Phase 3 The Manila Times

Karolinska Development’s portfolio company SVF Vaccines presents positive data from a preclinical study of SVF-001 in chronic hepatitis B and D - The Manila Times

Karolinska Development’s portfolio company SVF Vaccines presents positive data from a preclinical study of SVF-001 in chronic hepatitis B and D The Manila Times

Karolinska Development's portfolio company PharmNovo receives approval to initiate a phase 2a trial of its drug candidate PN6047 in Spain - The Manila Times

Karolinska Development's portfolio company PharmNovo receives approval to initiate a phase 2a trial of its drug candidate PN6047 in Spain The Manila Times

Karolinska Development recruits John Öhd to the position of Chief Scientific Officer - NTB Kommunikasjon

Karolinska Development recruits John Öhd to the position of Chief Scientific Officer NTB Kommunikasjon

Mikaela is investment manager at Karolinska Development - Stockholms universitet

Mikaela is investment manager at Karolinska Development Stockholms universitet

Top Karolinska Development Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant